Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Airbnb Inc.

Start price
Target price
Perf. (%)
€145.62
02.05.21
€200.00
02.05.22
1.79%
13.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Reconnaissance Energy Afri.ltd

Start price
Target price
Perf. (%)
€1.69
12.01.21
-
12.01.22
214.20%
13.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
buy
Phunware Inc.

Start price
Target price
Perf. (%)
€2.19
06.01.22
-
06.01.23
10.04%
09.01.22

Risky Investment
buy
Everarc Holdings Ltd.

Start price
Target price
Perf. (%)
€6.30
14.08.21
€15.00
14.08.22
29.37%
08.01.22

ROE higher than 10% per year
Sustainability is important
very negative Cash Flow expected
Higher risks for its business
buy
Bridgebio Pharma Inc.

Start price
Target price
Perf. (%)
€12.20
27.12.21
€15.00
27.12.22
5.74%
08.01.22

Could be worthwhile Investment >10% per year
Good culture
Capable Management
No uniques
buy
Odonate Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.27
27.12.21
-
27.12.22
-24.02%
08.01.22

Could be worthwhile Investment >10% per year
Innovative
Good culture
Few uniques
buy
Medmen Enterprises Inc.

Start price
Target price
Perf. (%)
€0.12
05.01.21
€8.00
05.01.22
24.70%
06.01.22

Capable Management
Known brand
Future proof or reliable business model
buy
Up Fintech Holding Ltd.

Start price
Target price
Perf. (%)
€4.74
13.12.20
€28.00
23.10.24
-18.57%
06.01.22

buy
BioVaxys Technology Corp.

Start price
Target price
Perf. (%)
€0.13
30.12.20
€5.00
30.12.21
9.92%
31.12.21

Could be very worthwhile Investment >20% year
Strong uniques
Very Future proof/growth oriented business model
Leading role in innovation
buy
Powerhouse Energy Group Plc

Start price
Target price
Perf. (%)
€0.063
25.04.21
€16.00
25.04.22
-17.81%
26.12.21

Could be very worthwhile Investment >20% year
buy
Westwing Group AG

Start price
Target price
Perf. (%)
€31.42
25.12.20
€48.60
25.12.21
-29.59%
26.12.21

Could be worthwhile Investment >10% per year
buy
Argenx SE

Start price
Target price
Perf. (%)
€256.00
16.12.21
-
16.12.22
17.97%
25.12.21

Could be very worthwhile Investment >20% year
Argenx SE

Start price
Target price
Perf. (%)
€298.00
17.12.21
-
17.12.22
1.34%
25.12.21

Could be worthwhile Investment >10% per year
buy
Terns Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.45
12.12.21
-
12.12.22
3.67%
25.12.21

Could be worthwhile Investment >10% per year
buy
Odonate Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.27
13.12.21
-
13.12.22
7.87%
25.12.21

Could be worthwhile Investment >10% per year
Innovative
Good culture
Few uniques
buy
thyssenkrupp AG ADR

Start price
Target price
Perf. (%)
€9.55
06.12.21
-
06.12.22
-1.05%
23.12.21

buy
Delivery Hero SE NEUE

Start price
Target price
Perf. (%)
€130.80
17.12.21
€120.00
-
20.12.21

Could be worthwhile Investment >10% per year
Higher risks for its business
buy
Equillium Inc.

Start price
Target price
Perf. (%)
€3.82
21.12.20
€6.00
21.12.21
3.14%
20.12.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Risky balance sheet
buy
Christina Lake Cannabis Corp.

Start price
Target price
Perf. (%)
€0.49
19.12.20
€1.00
19.12.21
-65.57%
20.12.21

Could be very worthwhile Investment >20% year
Mereo Biopharma Group Ltd.

Start price
Target price
Perf. (%)
€2.74
18.12.20
-
18.12.21
-45.99%
19.12.21

Probably not worthwhile Investment
Humanigen Inc.

Start price
Target price
Perf. (%)
€6.70
10.09.21
€3.00
31.12.23
-43.58%
16.12.21

Could be very worthwhile Investment >20% year
buy
Navya S.a.

Start price
Target price
Perf. (%)
€3.86
14.12.20
€5.00
14.12.21
-42.05%
15.12.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Aim Immunotech Inc.

Start price
Target price
Perf. (%)
€1.51
14.12.20
€2.00
14.12.21
-35.89%
15.12.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Hensoldt AG

Start price
Target price
Perf. (%)
€13.99
13.12.20
-
13.12.21
-11.94%
14.12.21

Leading role in innovation
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Futu Holdings Ltd.

Start price
Target price
Perf. (%)
€58.00
19.10.21
€90.00
19.10.22
-36.21%
13.12.21

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
positive Cash Flow expected
Higher risks for its business